Literature DB >> 8775226

Endogenous tissue plasminogen activator in neonatal cerebrospinal fluid.

A Whitelaw1, M C Mowinckel, V Fellman, U Abildgaard.   

Abstract

Tissue type plasminogen activator (tPA) plays a role in differentiation of neurones and activity-dependent structural changes in neurones. We hypothesised that tPA would also be present in CSF during fibrinolysis after intraventricular haemorrhage. We measured tPA antigen in CSF from 13 normal newborn infants and 14 infants with post-haemorrhagic ventricular dilatation (PHVD). tPA was undetectable or at the limit of detection (1 microgram/l) in normal CSF. The CSF tPA concentration ranged from 1.3 to 3.5 micrograms/l in the infants with PHVD. Serial tapping in one infant showed persistence of tPA in the CSF from 3 to 8 weeks of age. We conclude that endogenous tPA may be part of the physiological response to intraventricular haemorrhage or may be present as a result of passive diffusion into the CSF.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8775226     DOI: 10.1007/bf02075763

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  18 in total

1.  Single intracisternal bolus of recombinant tissue plasminogen activator in patients with aneurysmal subarachnoid hemorrhage: preliminary assessment of efficacy and safety in an open clinical study.

Authors:  D Stolke; V Seifert
Journal:  Neurosurgery       Date:  1992-06       Impact factor: 4.654

2.  Tissue-type plasminogen activator, plasminogen activator inhibitor, and histidine-rich glycoproteins in stressed human newborns.

Authors:  J J Corrigan; M A Jeter
Journal:  Pediatrics       Date:  1992-01       Impact factor: 7.124

3.  Induction of morphological differentiation of human neuroblastoma cells is accompanied by induction of tissue-type plasminogen activator.

Authors:  T Neuman; R W Stephens; E M Salonen; T Timmusk; A Vaheri
Journal:  J Neurosci Res       Date:  1989-07       Impact factor: 4.164

4.  Neuronal plasminogen activators: cell surface binding sites and involvement in neurite outgrowth.

Authors:  R N Pittman; J K Ivins; H M Buettner
Journal:  J Neurosci       Date:  1989-12       Impact factor: 6.167

5.  Phase I trial of tissue plasminogen activator for the prevention of vasospasm in patients with aneurysmal subarachnoid hemorrhage.

Authors:  J M Zabramski; R F Spetzler; K S Lee; S M Papadopoulos; E Bovill; R S Zimmerman; J B Bederson
Journal:  J Neurosurg       Date:  1991-08       Impact factor: 5.115

6.  Lysis of intraventricular hematoma with tissue plasminogen activator. Case report.

Authors:  J M Findlay; B K Weir; D E Stollery
Journal:  J Neurosurg       Date:  1991-05       Impact factor: 5.115

7.  A potential mechanism of pathogenesis for early posthemorrhagic hydrocephalus in the premature newborn.

Authors:  A Hill; G D Shackelford; J J Volpe
Journal:  Pediatrics       Date:  1984-01       Impact factor: 7.124

8.  Fibrinolysis in cerebrospinal fluid after intraventricular haemorrhage.

Authors:  A Whitelaw; L Creighton; P Gaffney
Journal:  Arch Dis Child       Date:  1991-07       Impact factor: 3.791

9.  Intracisternal recombinant tissue plasminogen activator after aneurysmal subarachnoid hemorrhage.

Authors:  J M Findlay; B K Weir; N F Kassell; L B Disney; M G Grace
Journal:  J Neurosurg       Date:  1991-08       Impact factor: 5.115

10.  Effect of intrathecal fibrinolytic therapy on clot lysis and vasospasm in patients with aneurysmal subarachnoid hemorrhage.

Authors:  J Ohman; A Servo; O Heiskanen
Journal:  J Neurosurg       Date:  1991-08       Impact factor: 5.115

View more
  4 in total

1.  Management of intraventricular hemorrhage.

Authors:  Holly E Hinson; Daniel F Hanley; Wendy C Ziai
Journal:  Curr Neurol Neurosci Rep       Date:  2010-03       Impact factor: 5.081

2.  Phase I study of intraventricular recombinant tissue plasminogen activator for treatment of posthaemorrhagic hydrocephalus.

Authors:  A Whitelaw; E Saliba; V Fellman; M C Mowinckel; D Acolet; N Marlow
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1996-07       Impact factor: 5.747

3.  Intraventricular administration of recombinant tissue plasminogen activator for intraventricular hemorrhage in the newborn.

Authors:  Mete Akisu; Mehmet Yalaz; Sertac Arslanoglu; Nilgun Kultursay
Journal:  Neurosurg Rev       Date:  2003-06-11       Impact factor: 3.042

Review 4.  Biomarkers in neonatal posthemorrhagic hydrocephalus.

Authors:  Stephanie Merhar
Journal:  Neonatology       Date:  2011-07-27       Impact factor: 4.035

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.